A Bright Future for Hormones and Cancer: Farewell Comments of Dr. Carol A. Lange, Recent Past Editor-in-Chief

Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, D’Assoro AB, Ravindranathan P, Peng Y, Raj GV, Yee D, Lange CA (2014) Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene. doi:10.1038/onc.2013.579, 27 January 2014 Rechoum Y, Rovito D, Iacopetta D, Barone I, Andò S, Weigel NL, O’Malley BW, Brown PH, Fuqua SA (2014) AR collaborates with ERα in aromatase inhibitor-resistant breast cancer. Breast Cancer Res Treat 147:473–485 Takizawa I, Lawrence MG, Balanathan P, Rebello R, Pearson HB, Garg E, Pedersen J, Pouliot N, Nadon R, Watt MJ, Taylor R6, Humbert P, Topisirovic I, Larsson O, Risbridger GP, Furic L (2014) Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity. Oncotarget 2014 Nov 26 Jeong Y, Xie Y, Xiao G, Behrens C, Girard L, Wistuba II, Minna JD, Mangelsdorf DJ (2010) Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med 7:e1000378